Common transcriptional signatures in brain tissue from patients with hiv-associated neurocognitive disorders, Alzheimer's disease, and multiple sclerosis

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 4, 2012, Pages 914-926

  Borjabad, Alejandra ^a,b   Volsky, David J ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Alzheimer's disease; HAND; HIV; Microarrays; Multiple sclerosis; Transcriptome meta analysis

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; TRANSCRIPTOME;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; FRONTAL LOBE; FUNCTIONAL GENOMICS; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; META ANALYSIS (TOPIC); MULTIGENE FAMILY; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TISSUE MICROARRAY; TRANSCRIPTION REGULATION; UPREGULATION; WHITE MATTER;

AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; ANTIGEN PRESENTATION; BRAIN CHEMISTRY; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84875866595     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9409-5     Document Type: Article

References (102)

1. Alisky JM (2007) The coming problem of HIV-associated Alzheimer's disease. Med Hypotheses 69:1140-1143
2. Antinori A et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
3. Attia M, Förster A, Rachez C, Freemont P, Avner P, Rogner UC (2011) Interaction between nucleosome assembly protein 1-like family members. J Mol Biol 407:647-660
4. Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, Yoshioka M, Houff S, Sheremata W, Horton GF, Landy H (1992) Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol 31:34-38
5. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101:2173-2178
6. Blalock EM, Chen KC, Stromberg AJ, Norris CM, Kadish I, Kraner SD, Porter NM, Landfield PW (2005) Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation. Ageing Res Rev 4:481-512
7. Borjabad A, Brooks AI, Volsky DJ (2010) Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5:44-62
8. Borjabad A, Morgello S, Chao W, Kim S-Y, Brooks AI, Murray J, Potash MJ, Volsky DJ (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 7:e1002213
9. Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF (2010) Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 133:3699-3723
10. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, Starkey MP (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res 1127:127-135
11. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462-473
12. Cooper-Knock J, Kirby J, Ferraiuolo L, Heath PR, Rattray M, Shaw PJ (2012) Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol 8:518-530
13. Corral I, Quereda C, Garcia-Villanueva M, Casado JL, Perez-Elias MJ, Navas E, Ariza A, Moreno S (2004) Focal monophasic demyelinating leukoencephalopathy in advanced HIV infection. Eur Neurol 52:36-41
14. Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, Mufson EJ (2007) Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol 64:1771-1776
15. Cubelos B, Sebastian-Serrano A, Beccari L, Calcagnotto ME, Cisneros E, Kim S, Dopazo A, Alvarez-Dolado M, Redondo JM, Bovolenta P, Walsh CA, Nieto M (2010) Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 66:523-535
16. D'Agata V, Cavallaro S (2004) Genomic portraits of the nervous system in health and disease. Neurochem Res 29:1201-1212
17. Dutta R, Trapp BD (2010) Gene expression profiling in multiple sclerosis brain. Neurobiol Dis
18. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478-489
19. Dutta R, McDonough J, Chang A, Swamy L, Siu A, Kidd GJ, Rudick R, Mirnics K, Trapp BD (2007) Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 130:2566-2576
20. Ehrnhoefer DE, Wong BK, Hayden MR (2011) Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. Nat Rev Drug Discov 10:853-867
21. Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33-44
22. Emilsson L, Saetre P, Jazin E (2006) Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis 21:618-625
23. Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986) Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78:678-687
24. Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E (2005) Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 170:158-171
25. Everall IP, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E (2006) Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology 67:1867-1869
26. Ferrer I, Gomez A, Carmona M, Huesa G, Porta S, Riera-Codina M, Biagioli M, Gustincich S, Aso E (2011) Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies. J Alzheimers Dis 23:537-550
27. Gelman BB, Soukup VM, Schuenke KW, Keherly MJ, Holzer C 3rd, Richey FJ, Lahart CJ (2004) Acquired neuronal channelopathies in HIV-associated dementia. J Neuroimmunol 157:111-119
28. Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV, Mufson EJ, Nixon RA, Che S (2010) Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry 68:885-893
29. Glanzer JG, Haydon PG, Eberwine JH (2004) Expression profile analysis of neurodegenerative disease: advances in specificity and resolution. Neurochem Res 29:1161-1168
30. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554-573
31. Grunblatt E (2004) The benefits of microarrays as tools for studying neuropsychiatric disorders. Drugs Today (Barc) 40:147-156
32. Grunblatt E, Zander N, Bartl J, Jie L, Monoranu CM, Arzberger T, Ravid R, Roggendorf W, Gerlach M, Riederer P (2007) Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease. J Alzheimers Dis 12:291-311
33. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 25:625-633
34. Hawrylycz MJ et al (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489:391-399
35. Heaton RK et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
36. Higgs BW, Elashoff M, Richman S, Barci B (2006) An online database for brain disease research. BMC Genomics 7:70
37. Hoheisel JD (2006) Microarray technology: beyond transcript profiling and genotype analysis. Nat Rev Genet 7:200-210
38. Holler CJ, Webb RL, Laux AL, Beckett TL, Niedowicz DM, Ahmed RR, Liu Y, Simmons CR, Dowling AL, Spinelli A, Khurgel M, Estus S, Head E, Hersh LB, Murphy MP (2012) BACE2 expression increases in human neurodegenerative disease. Am J Pathol 180:337-350
39. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067-1081
40. Hoozemans JJM, Rozemuller AJM, van Haastert ES, Eikelenboom P, van Gool WA (2011) Neuroinflammation in Alzheimer's disease wanes with age. J Neuroinflammation 8:171
41. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70
42. Jee SW, Cho JS, Kim CK, Hwang DY, Shim SB, Lee SH, Sin JS, Kim YS, Park JH, Choi SY, Kim YK (2007) Analysis of differentially expressed genes in early- and late-stage APPsw-transgenic and normal mice using cDNA microarray. Int J Mol Med 19:461-468
43. Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL (2010) Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One 5:e12278
44. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532-540
45. Katsel PL, Davis KL, Haroutunian V (2005) Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63:41-82
46. Katsel P, Li C, Haroutunian V (2007) Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 32:845-856
47. Kawamoto EM, Vivar C, Camandola S (2012) Physiology and pathology of calcium signaling in the brain. Front Pharmacol 3:61
48. Khandelwal PJ, Herman AM, Moussa CE (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238:1-11
49. Kinter J, Zeis T, Schaeren-Wiemers N (2008) RNA profiling of MS brain tissues. Int MS J 15:51-58
50. Kropp M, Wilson SI (2012) The expression profile of the tumor suppressor gene Lzts1 suggests a role in neuronal development. Dev Dyn 241:984-994
51. Lackner P, Kuenz B, Reindl M, Morandell M, Berger T, Schmutzhard E, Eggers C (2010) Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study. J Neuroinflammation 7:79
52. Lindberg RL, Kappos L (2006) Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment. Expert Rev Mol Diagn 6:843-855
53. Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D (2004) Multiple sclerosis as a generalized CNS disease-comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J Neuroimmunol 152:154-167
54. Lipton S, Gendelman HE (1995) Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 233:934-940
55. Lopez-Villegas D, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 94:9854-9859
56. Lu SM, Tong N, Gelbard HA (2007) The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation. J Neuroimmune Pharmacol 2:194-201
57. Lu SM, Tremblay ME, King IL, Qi J, Reynolds HM, Marker DF, Varrone JJ, Majewska AK, Dewhurst S, Gelbard HA (2011) HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 6:e23915
58. Lukasiuk K, Pitkänen A (2004) Large-scale analysis of gene expression in epilepsy research: is synthesis already possible? Neurochem Res 29:1169-1178
59. Maccioni RB, Munoz JP, Barbeito L (2001) The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32:367-381
60. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS (2004) Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157:163-175
61. Melzer S, Michael M, Caputi A, Eliava M, Fuchs EC, Whittington MA, Monyer H (2012) Long-range-projecting GABAergic neurons modulate inhibition in hippocampus and entorhinal cortex. Science 335:1506-1510
62. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23
63. Minagar A, Shapshak P, Duran EM, Kablinger AS, Alexander JS, Kelley RE, Seth R, Kazic T (2004) HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review. J Neurol Sci 224:3-17
64. Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK (2010) Animal models of multiple sclerosis-potentials and limitations. Prog Neurobiol 92:386-404
65. Navia BA, Price RW (1987) The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus type infection. Arch Neurol 44:65-69
66. Navia BA, Jordan BD, Price RW (1986a) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517-524
67. Navia BA, Cho ES, Petito CK, Price RW (1986b) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525-535
68. Noorbakhsh F, Overall CM, Power C (2009) Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 32:88-100
69. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
70. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW (2007) Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 28:1821-1833
71. Park B, Lee W, Han K (2012) Modeling the interactions of Alzheimer-related genes from the whole brain microarray data and diffusion tensor images of human brain. BMC Bioinforma 13(Suppl 7):S10
72. Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E (2004) A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clin Cancer Res 10:2922-2927
73. Pasinetti GM (2001) Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 65:471-476
74. Prinzen C, Trumbach D, Wurst W, Endres K, Postina R, Fahrenholz F (2009) Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice. BMC Genomics 10:66
75. Pulliam L (2009) HIV regulation of amyloid beta production. J Neuroimmune Pharmacol 4:213-217
76. Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19:127-135
77. Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O (2011) The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol 122:155-170
78. Richman DD (2001) HIV chemotherapy. Nature 410:995-1001
79. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915-1921
80. Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V (2012) A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 1-11
81. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142
82. Sailasuta N, Shriner K, Ross B (2009) Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 22:326-331
83. Salaria S, Badkoobehi H, Rockenstein E, Crews L, Chana G, Masliah E, Everall IP (2007) Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J Neurovirol 13:496-503
84. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
85. Shapshak P, Duncan R, Torres-Muñoz JE, Duran EM, Minagar A, Petito CK (2004) Analytic approaches to differential gene expression in AIDS versus control brains. Front Biosci 9:2935-2946
86. Shapshak P, Rodriguez HE, Kayathri R, Levine A, Chiappelli F, Minagar A (2008) Alzheimer's disease and HIV associated dementia related genes: I. location and function. Bioinformation 2:348-357
87. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243-1250
88. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423
89. Steinman L, Zamvil S (2003) Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 3:483-492
90. Stephens EB, Jackson M, Cui L, Pacyniak E, Choudhuri R, Liverman CS, Salomon DS, Berman NE (2006) Early dysregulation of cripto-1 and immunomodulatory genes in the cerebral cortex in a macaque model of neuroAIDS. Neurosci Lett 410:94-99
91. Sun W, Maffie JK, Lin L, Petralia RS, Rudy B, Hoffman DA (2011) DPP6 establishes the A-type K(+) current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons. Neuron 71:1102-1115
92. Tajouri L, Mellick AS, Ashton KJ, Tannenberg AE, Nagra RM, Tourtellotte WW, Griffiths LR (2003) Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res 119:170-183
93. Tajouri L, Fernandez F, Griffiths LR (2007) Gene expression studies in multiple sclerosis. Curr Genomics 8:181-189
94. Tan PK, Downey TJ, Spitznagel EL Jr, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM, Cam MC (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucl Acids Res 31:5676-5684
95. Torkildsen O, Stansberg C, Angelskar SM, Kooi EJ, Geurts JJ, van der Valk P, Myhr KM, Steen VM, Bo L (2010) Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 20:720-729
96. Tseveleki V, Rubio R, Vamvakas SS, White J, Taoufik E, Petit E, Quackenbush J, Probert L (2010) Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes. Genomics 96:82-91
97. Walker PR, Smith B, Liu QY, Famili AF, Valdes JJ, Liu Z, Lach B (2004) Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 31:137-154
98. Wilcox KC, Lacor PN, Pitt J, Klein WL (2011) Abeta oligomer-induced synapse degeneration in Alzheimer's disease. Cell Mol Neurobiol 31:939-948
99. Xia Z, Storm DR (2005) The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6:267-276
100. Yu W, Lu B (2012) Synapses and dendritic spines as pathogenic targets in Alzheimer's disease. Neural Plast 2012:247150
101. Zhou L, Diefenbach E, Crossett B, Tran SL, Ng T, Rizos H, Rua R, Wang B, Kapur A, Gandhi K, Brew BJ, Saksena NK (2010) First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia. Mol Neurodegener 5:27
102. Zilka N, Kazmerova Z, Jadhav S, Neradil P, Madari A, Obetkova D, Bugos O, Novak M (2012) Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation 9:47